Shanghai, China · Founded 2013 · Privately Held (backing)
Developer of gene editing and cell engineering platforms intended for genetic and immune-related disorders. BRL Medicine is based in Shanghai, China and was founded in 2013. It has raised $55.6 million.
Last price · $/share
—
Implied valuation
—
Total raised
$55.6M
Last round
—
How much has BRL Medicine raised?
$55.6Macross 0 recorded rounds
Free account
More of BRL Medicine with a free account
·The complete investor list: 14 names
·Watch BRL Medicine: the Monday email on marks, rounds and moves